<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We administered <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> to patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and pure red-cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> as a multicenter clinical trial </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> was given by a dose of 6 mg/kg orally daily for 16 weeks </plain></SENT>
<SENT sid="2" pm="."><plain>The efficacy of cyclosporin for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> was 13.8% after 8 weeks, and 28.0% after 16 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>The severity of the disease was improved, and the amount of blood transfusion was reduced </plain></SENT>
<SENT sid="4" pm="."><plain>The efficacy of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> for patients with pure red-cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> was 60.0% at 16 weeks treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Adverse effects of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> were observed in some patients and the <z:hpo ids='HP_0001007'>hirsutism</z:hpo> was seen most commonly </plain></SENT>
<SENT sid="6" pm="."><plain>In laboratory data, an increase of serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> was seen but was transient </plain></SENT>
<SENT sid="7" pm="."><plain>Our results showed that <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> is an effective drug for treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and pure red-cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> </plain></SENT>
</text></document>